Member Exclusive

Diabetes drug fights memory loss in mice with Alzheimer’s

Originally developed to treat type 2 diabetes, the triple GLP-1/GIP/glucagon receptor agonist was found to 'significantly reverse memory loss'.

Go to the profile of Freya Leask
Jan 03, 2018

Please sign in or register for FREE

Register to RegMedNet – the regenerative medicine network

RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.


No comments yet.